Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.37 | - | - |
| Perrigo Co. plc | 3 | 0 | 0 | 0 | €28.50 | €35.99 | 26.264% |
| Pfizer Inc. | 31 | 4 | 3 | 0 | €26.01 | €41.10 | 58.028% |
| Boston Scientific | 46 | 0 | 10 | 0 | €68.50 | €73.05 | 6.638% |
| Henry Schein Inc. | 12 | 1 | 1 | 0 | €67.70 | €79.48 | 17.399% |
| Centene Corp. | 15 | 0 | 3 | 0 | €72.22 | €82.57 | 14.332% |
| Hologic Inc. | 17 | 0 | 4 | 0 | €70.00 | €84.52 | 20.744% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €61.21 | €86.77 | 41.760% |
| Edwards Lifesciences Corp. | 26 | 1 | 4 | 0 | €80.49 | €88.14 | 9.501% |
| Medtronic plc | 9 | 1 | 0 | 0 | €76.91 | €93.46 | 21.513% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €97.22 | €116.81 | 20.148% |
| Davita Inc. | 2 | 0 | 0 | 0 | €127.65 | €124.89 | -2.164% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €120.80 | €124.93 | 3.418% |
| Agilent Technologies Inc. | 17 | 3 | 0 | 0 | €139.04 | €134.50 | -3.264% |
| Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | €128.50 | €144.44 | 12.408% |
| Universal Health Services B | 9 | 3 | 1 | 0 | €163.00 | €159.70 | -2.022% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €149.20 | €174.43 | 16.913% |
| Johnson & Johnson | 32 | 1 | 3 | 0 | €139.16 | €196.74 | 41.374% |
| Zoetis Inc. A | 23 | 1 | 5 | 0 | €156.94 | €200.06 | 27.474% |
| Resmed Inc. | 19 | 0 | 3 | 0 | €198.50 | €203.18 | 2.356% |
| Laboratory Corp. Of America (labcorp) | 11 | 0 | 2 | 0 | €188.00 | €237.94 | 26.564% |
| Teleflex Inc. | 10 | 0 | 0 | 0 | €187.00 | €247.18 | 32.181% |
| Becton, Dickinson & Co. | 9 | 0 | 1 | 0 | €218.80 | €268.91 | 22.901% |
| Biogen Inc. | 46 | 1 | 6 | 1 | €205.70 | €294.01 | 42.932% |
| Amgen Inc. | 25 | 0 | 6 | 0 | €287.90 | €297.31 | 3.269% |